Bath & Body Works, Inc. (NYSE:BBWI) Receives Consensus Recommendation of “Hold” from Brokerages

Bath & Body Works, Inc. (NYSE:BBWI) has earned a consensus recommendation of “Hold” from the fourteen analysts that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating on the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $46.33.

Several analysts recently weighed in on BBWI shares. Barclays downgraded Bath & Body Works from an “overweight” rating to an “equal weight” rating and upped their price target for the stock from $37.00 to $45.00 in a research note on Thursday, January 4th. Telsey Advisory Group restated an “outperform” rating and issued a $53.00 price target on shares of Bath & Body Works in a research note on Friday, April 5th. Robert W. Baird upped their price target on Bath & Body Works from $50.00 to $54.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. BMO Capital Markets upped their price target on Bath & Body Works from $48.00 to $50.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. Finally, Evercore ISI upped their price target on Bath & Body Works from $30.00 to $45.00 and gave the stock an “in-line” rating in a research note on Friday, March 1st.

Bath & Body Works Stock Performance

BBWI stock opened at $43.17 on Friday. Bath & Body Works has a fifty-two week low of $27.30 and a fifty-two week high of $50.34. The business’s 50 day moving average price is $46.18 and its two-hundred day moving average price is $39.98. The company has a market capitalization of $9.71 billion, a price-to-earnings ratio of 11.21, a price-to-earnings-growth ratio of 1.45 and a beta of 1.86.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.21. The firm had revenue of $2.91 billion for the quarter, compared to the consensus estimate of $2.84 billion. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The business’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.86 EPS. Sell-side analysts forecast that Bath & Body Works will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Investors of record on Friday, February 23rd were given a $0.20 dividend. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $0.80 annualized dividend and a yield of 1.85%. Bath & Body Works’s dividend payout ratio (DPR) is presently 20.78%.

Insider Activity

In other news, insider Thomas E. Mazurek sold 4,285 shares of the stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the transaction, the insider now directly owns 45,992 shares of the company’s stock, valued at approximately $2,248,548.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.19% of the company’s stock.

Hedge Funds Weigh In On Bath & Body Works

Several hedge funds and other institutional investors have recently modified their holdings of the company. Atlas Capital Advisors LLC increased its stake in shares of Bath & Body Works by 3.8% in the 1st quarter. Atlas Capital Advisors LLC now owns 14,063 shares of the company’s stock worth $703,000 after purchasing an additional 521 shares in the last quarter. Kwmg LLC increased its stake in shares of Bath & Body Works by 1.0% in the 1st quarter. Kwmg LLC now owns 119,526 shares of the company’s stock worth $5,979,000 after purchasing an additional 1,136 shares in the last quarter. First Financial Corp IN increased its stake in shares of Bath & Body Works by 30.0% in the 1st quarter. First Financial Corp IN now owns 2,571 shares of the company’s stock worth $129,000 after purchasing an additional 594 shares in the last quarter. FCF Advisors LLC increased its stake in shares of Bath & Body Works by 9.7% in the 1st quarter. FCF Advisors LLC now owns 35,055 shares of the company’s stock worth $1,753,000 after purchasing an additional 3,112 shares in the last quarter. Finally, Contravisory Investment Management Inc. purchased a new stake in shares of Bath & Body Works in the 1st quarter worth $487,000. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.